LATEST NEWS

June 25, 2026

HKeyBio Launches NHP Fast-Tox Program for Accelerating Non-GLP NHP Safety Risk Screening

June 25, 2026

HKeyBio Debuts HKEY-ExE™ 1.0 to Address Preclinical Bottlenecks in EoE and EgE Drug Development

June 10, 2026

HkeyBio Launches "NHP Fast-PoC" Program to Deliver Low-Cost Cyno PK/PD and Developability Data Amid Rising NHP Prices

April 20, 2026

HKeybio Launches World's First NHP Hidradenitis Suppurativa Model with High Clinical Consistency To Tackle Global Drug R&D Bottleneck

HKeybio Tech., a global leader in non-human primate (NHP) experimental animal model research and development, today announced the official launch of the world's first NHP Hidradenitis Suppurativa (HS) model, based on over ten years of research and development involving more than 200 NHP subjects. Th

April 02, 2026

HKeyBio Launches HKEY-NHP-onChip™ 1.1: World's First NHP In Vitro Model for Autoimmune and Allergic Diseases

HKeyBio, a global leading CRO specializing in preclinical and translational research for autoimmune and allergic diseases, today officially announced the launch of its HKEY-NHP-onChip™ 1.1 platform — the world’s first non-human primate (NHP) in vitro model system dedicated to autoimmune and allergic

ChatGPT Image 2026年5月26日 15_44_19_1485_835.png

May 27, 2026

Deepening Focus on Autoimmune Diseases, Empowering AI-Driven Drug Discovery

HKeyBio is a China-based, globally-focused preclinical CRO dedicated exclusively to the fields of autoimmune and allergic diseases.

CONTACT US

Phone: +1 2396821165
Email: tech@hkeybio.com
Add: Boston site 「134 Coolidge Ave, Suite 2, Watertown, MA 02472」

China site「Room 205, Building B, Ascendas iHub Suzhou, Singapore Industrial Park, Jiangsu」

LATEST NEWS

CONTACT US

QUICK LINKS

PRODUCTS CATEGORY

SIGN UP FOR OUR NEWSLETTER